Does Pediatric Obstructive Sleep Apnea Syndrome Cause Systemic Microvascular Dysfunction?

Area of Science:

• Pediatric Pulmonology
• Cardiovascular Research
• Sleep Medicine

Background:

• Obstructive sleep apnea syndrome (OSAS) in children, often due to adenoid hypertrophy, is a growing concern.
• The potential impact of pediatric OSAS on systemic microvascular function remains incompletely understood.
• Early identification of cardiovascular risks associated with pediatric OSAS is crucial for timely intervention.

Purpose of the Study:

• To investigate whether pediatric OSAS secondary to adenoid hypertrophy leads to systemic microvascular dysfunction.
• To assess potential early cardiovascular risks in children diagnosed with OSAS.
• To evaluate microvascular parameters in relation to the severity of OSAS.

Main Methods:

• A prospective, single-blinded, case-control study involving 81 pediatric patients with OSAS and 26 healthy controls.
• OSAS severity was categorized as mild, moderate, or severe based on lateral nasopharynx X-ray.
• Videocapillaroscopy assessed nailfold capillary density (CD) and postocclusive reactive hyperemia (PORH) to evaluate microvascular function.

Main Results:

• No statistically significant differences were observed in capillary density (CD) among the control group and the mild, moderate, and severe OSAS groups (P > 0.05).
• Postocclusive reactive hyperemia (PORH) measurements also showed no significant variations across the different OSAS severity groups and the control group (P > 0.05).
• The duration of symptoms in OSAS patients ranged from 6 months to less than 1 year.

Conclusions:

• Pediatric OSAS secondary to adenoid hypertrophy does not appear to cause systemic microvascular dysfunction in the early stages.
• The study suggests that early-stage pediatric OSAS, as evaluated by these microvascular parameters, does not carry an immediate cardiovascular risk.
• Further research may be warranted to explore long-term effects or other potential indicators of cardiovascular risk in this population.